These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1619577)

  • 1. Determination of fenoverine, a modulator of smooth muscle motility, in capsules and in human plasma: application to dosage form stability and a pilot study in humans.
    Hu OY; Chen PH; Fang YJ; Tang HS; Pao LH; Kwok KM; King ML
    J Pharm Sci; 1992 Jan; 81(1):91-3. PubMed ID: 1619577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of fenoverine in tissue samples by high-performance liquid chromatography.
    Ratiney R; Astier A; Chariot P
    J Chromatogr B Biomed Appl; 1994 Mar; 654(1):159-63. PubMed ID: 8004239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenoverine-induced rhabdomyolysis.
    Chariot P; Ratiney R; Le Maguet F; Fourestié V; Astier A; Gherardi R
    Hum Exp Toxicol; 1995 Aug; 14(8):654-6. PubMed ID: 7576832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic profile of fenoverine, a novel modulator of smooth muscle motility.
    De Santis D; Marrazzo R; Losasso C; Loffreda A; De Paola C; De Novellis V; Molinario L; Schiariti F; Marmo E
    Drugs Exp Clin Res; 1989; 15(1):37-42. PubMed ID: 2743871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoverine: a two-step, double-blind and open clinical assessments of its smooth muscle synchronizing effects.
    Bader F
    Pharmatherapeutica; 1986; 4(7):422-8. PubMed ID: 3515369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenoverine: a novel synchronizer of smooth muscle motility by interference with cellular calcium flow.
    Gonella J; Lalanne C; Mironneau J
    Curr Med Res Opin; 1987; 10(7):427-35. PubMed ID: 3113828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoverine inhibition of calcium channel currents in single smooth muscle cells from rat portal vein and myometrium.
    Mironneau J; Arnaudeau S; Mironneau C
    Br J Pharmacol; 1991 Sep; 104(1):65-70. PubMed ID: 1786520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research into individual predisposition to develop acute rhabdomyolysis attributed to fenoverine.
    Jouglard J; Kozak-Ribbens G; de Haro L; Cozzone PJ
    Hum Exp Toxicol; 1996 Oct; 15(10):815-20. PubMed ID: 8906430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific and rapid HPLC assay for the determination of cefroxadine in human plasma and its application to pharmacokinetic study in Korean.
    Kang YS; Lee SY; Kim NH; Choi HM; Park JS; Kim W; Lee HJ
    J Pharm Biomed Anal; 2006 Feb; 40(2):369-74. PubMed ID: 16137854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence, risk factors, and clinical outcomes of rhabdomyolysis associated with fenoverine prescription: a retrospective study in South Korea (1999-2014).
    Cho J; Na J; Bae E; Lee TW; Jang HN; Cho HS; Chang SH; Park DJ
    BMC Pharmacol Toxicol; 2020 Apr; 21(1):30. PubMed ID: 32334639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct injection HPLC method for the determination of selected phenothiazines in plasma using a Hisep column.
    Pistos C; Stewart JT
    Biomed Chromatogr; 2003 Oct; 17(7):465-70. PubMed ID: 14598331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the R,R- and S,S-enantiomers of vamicamide in human serum and urine by high-performance liquid chromatography on a Chiral-AGP column.
    Suzuki A; Takagaki S; Suzuki H; Noda K
    J Chromatogr; 1993 Aug; 617(2):279-84. PubMed ID: 8408394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Validated Stability-Indicating and Stereoselective HPLC Method for the Determination of Lenalidomide Enantiomers in Bulk Form and Capsules.
    Alzoman NZ
    J Chromatogr Sci; 2016; 54(5):730-5. PubMed ID: 26850732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic assay of trandolapril in capsules.
    Gumieniczek A; Hopkała H
    Acta Pol Pharm; 2000; 57(4):253-5. PubMed ID: 11126611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of high-dosage naftopidil capsules in dogs].
    Ding JS; Jiang XH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):425-7. PubMed ID: 12536488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics.
    Zhao WJ; Wang BJ; Wei CM; Yuan GY; Bu FL; Guo RC
    J Clin Pharm Ther; 2008 Jun; 33(3):289-94. PubMed ID: 18452416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC determination and pharmacokinetic study of tenatoprazole in dog plasma after oral administration of enteric-coated capsule.
    Liu P; Sun B; Lu X; Qin F; Li F
    Biomed Chromatogr; 2007 Jan; 21(1):89-93. PubMed ID: 17080510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive high-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma.
    Stiff DD; Frye RF; Branch RA
    J Chromatogr; 1993 Mar; 613(1):127-31. PubMed ID: 8458889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoverine: smooth muscle synchronizer for the management of gastro-intestinal conditions. II. A trimebutine-controlled, double-blind, crossover clinical evaluation.
    Camarri E
    Curr Med Res Opin; 1986; 10(1):52-7. PubMed ID: 3516580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.